Nuclear factor-kappa B (NF-kappa B) is a set of five polypeptide transcript
ion factors, called p50, p52, p65 (also called Rel A), Rel B, and c-Rel, wh
ich regulate the expression of a variety of genes involved in immune and in
flammatory responses, They were originally named because they were consider
ed essential regulators of B cell kappa light chain expression. More recent
studies indicate that NF-kappa B proteins are involved in the regulation o
f a variety of other cell functions, including cell proliferation, response
s to stress, and apoptosis, NF-kappa B heterodimers reside in the cytoplasm
of cells bound to inhibitory proteins, the two commonest of which are I ka
ppa B alpha and I kappa B beta, which prevent NF-kappa B from entering the
nucleus. When cells are stimulated, I kappa B is phosphorylated by specific
I kappa B kinases and subsequently is ubiquitinated and degraded in proteo
somes, This allows NF-kappa B to translocate to the nucleus to regulate the
expression of a growing list of genes, including the proinflammatory cytok
ines, interleukin-1 (IL-1), IL-6, and tumor necrosis factor. IL-1 and tumor
necrosis factor in turn also regulate the expression of NF-kappa B, Thus,
once activated, NF-kappa B may be involved in upregulatory loops, which can
amplify the effects of the initiating stimulus, Because these proinflammat
ory cytokines have been implicated in the pathogenesis of estrogen deficien
cy and inflammation-related bone loss, it is likely that NF-kappa B has a s
ignificant role in the increased generation and function of osteoclasts in
these circumstances. However, an unexpected and essential role of NF-kappa
B in the formation of osteoclasts during development was discovered recentl
y after the generation of knockout mice, which lack the expression of the p
50 and p52 subunits, This paper Kill describe recent studies that reveal an
essential role for NF-kappa B signaling in the generation of osteoclasts a
nd that suggest that NF-kappa B may also play a key central role in the act
ivation and survival of osteoclasts in conditions in which osteoclastogenes
is is upregulated, (C) 1999 by Elsevier Science Inc. All rights reserved.